mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0004 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
0.0004 |
mRNA |
NG-25 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0005 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0009 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |